Rationale, design, and organization of a randomized, controlled Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS) in patients with type 2 diabetes and established cardiovascular disease

Controlled Trial ◽

Cardiovascular Outcomes ◽

Effects of vitamins C and E and β-carotene on the risk of type 2 diabetes in women at high risk of cardiovascular disease: a randomized controlled trial

American Journal of Clinical Nutrition ◽

10.3945/ajcn.2009.27491 ◽

2009 ◽

Vol 90 (2) ◽

pp. 429-437 ◽

Cited By ~ 93

Author(s):

Yiqing Song ◽

Nancy R Cook ◽

Christine M Albert ◽

Martin Van Denburgh ◽

JoAnn E Manson

Keyword(s):

Type 2 Diabetes ◽

Cardiovascular Disease ◽

High Risk ◽

Controlled Trial ◽

Randomized Controlled ◽

Β Carotene

Subcutaneous infusion of exenatide and cardiovascular outcomes in type 2 diabetes: a non-inferiority randomized controlled trial

Nature Medicine ◽

10.1038/s41591-021-01584-3 ◽

2021 ◽

Author(s):

Christian T. Ruff ◽

Michelle Baron ◽

KyungAh Im ◽

Michelle L. O’Donoghue ◽

Fred T. Fiedorek ◽

...

Keyword(s):

Type 2 Diabetes ◽

Controlled Trial ◽

Cardiovascular Outcomes ◽

Subcutaneous Infusion ◽

Effects of Cardiovascular Disease Risk Communication for Patients With Type 2 Diabetes on Risk Perception in a Randomized Controlled Trial: The @RISK Study

Diabetes Care ◽

10.2337/dc11-2130 ◽

2012 ◽

Vol 35 (12) ◽

pp. 2485-2492 ◽

Cited By ~ 18

Author(s):

L. M. C. Welschen ◽

S. D. M. Bot ◽

P. J. Kostense ◽

J. M. Dekker ◽

D. R. M. Timmermans ◽

...

Keyword(s):

Type 2 Diabetes ◽

Cardiovascular Disease ◽

Risk Perception ◽

Risk Communication ◽

Disease Risk ◽

Controlled Trial ◽

Motivational interviewing and problem solving treatment to reduce type 2 diabetes and cardiovascular disease risk in real life: a randomized controlled trial

International Journal of Behavioral Nutrition and Physical Activity ◽

10.1186/1479-5868-10-47 ◽

2013 ◽

Vol 10 (1) ◽

pp. 47 ◽

Cited By ~ 47

Author(s):

Jeroen Lakerveld ◽

Sandra D Bot ◽

Mai J Chinapaw ◽

Maurits W van Tulder ◽

Piet J Kostense ◽

...

Keyword(s):

Type 2 Diabetes ◽

Cardiovascular Disease ◽

Problem Solving ◽

Disease Risk ◽

Controlled Trial ◽

Real Life ◽

Design of a Randomized Controlled Trial of a Web-Based Intervention to Reduce Cardiovascular Disease Risk Factors Among Remote Reservation–Dwelling American Indian Adults with Type 2 Diabetes

The Journal of Primary Prevention ◽

10.1007/s10935-012-0276-x ◽

2012 ◽

Vol 33 (4) ◽

pp. 209-222 ◽

Cited By ~ 10

Author(s):

Jeffrey A. Henderson ◽

◽

Jessica Chubak ◽

Joan O’Connell ◽

Maria C. Ramos ◽

...

Keyword(s):

Risk Factors ◽

Type 2 Diabetes ◽

Cardiovascular Disease ◽

Disease Risk ◽

Controlled Trial ◽

Web Based ◽

Review of article: Chronic ingestion of flavan-3-ols and isoflavones improves insulin sensitivity and lipoprotein status and attenuates estimated 10-year cardiovascular disease risk in medicated postmenopausal women with type 2 diabetes: A 1-year, double-blind, randomized, controlled trial by Peter J. Curtis, PhD, Mike Sampson, MD, John Potter, MD, Ketan Dhatariya, MD, Paul A. Kroon, PhD, Aedin Cassidy, PhD (Diabetes Care 2012;35:226–32)

Journal of Vascular Nursing ◽

10.1016/j.jvn.2012.12.001 ◽

2013 ◽

Vol 31 (1) ◽

pp. 56

Author(s):

Lily Thomson

Keyword(s):

Type 2 Diabetes ◽

Cardiovascular Disease ◽

Disease Risk ◽

Controlled Trial ◽

Double Blind ◽

Randomized Controlled ◽

Chronic Ingestion

Intervention of the Flash Glucose Sensing Technology on Glycemic Control and Treatment Satisfaction in Patients with Type 2 Diabetes Treated Intensively by Insulin—A Randomized Controlled Trial

Diabetes ◽

10.2337/db18-908-p ◽

2018 ◽

Vol 67 (Supplement 1) ◽

pp. 908-P ◽

Cited By ~ 1

Author(s):

MARIANNA YARON ◽

EYTAN ROITMAN ◽

GENYA AHARON-HANANEL ◽

ZOHAR LANDAU ◽

TALI GANZ ◽

...

Keyword(s):

Type 2 Diabetes ◽

Glycemic Control ◽

Treatment Satisfaction ◽

Controlled Trial ◽

Glucose Sensing ◽

Randomized Controlled ◽

Sensing Technology

110-LB: The Korean Titration: A Randomized Controlled Trial to Evaluate the Efficacy and Safety of Self-Titration Algorithms of Insulin Glargine 300 Units/ml in Patients with Uncontrolled Type 2 Diabetes

Diabetes ◽

10.2337/db20-110-lb ◽

2020 ◽

Vol 69 (Supplement 1) ◽

pp. 110-LB

Author(s):

JAE HYUN BAE ◽

CHANG HO AHN ◽

YE SEUL YANG ◽

SUN JOON MOON ◽

SOO HEON KWAK ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Controlled Trial ◽

Efficacy And Safety ◽

1126-P: Randomized Controlled Trial of Ipragliflozin or Sitagliptin Combined with Metformin in Type 2 Diabetes: NISM Study

Diabetes ◽

10.2337/db20-1126-p ◽

2020 ◽

Vol 69 (Supplement 1) ◽

pp. 1126-P

Author(s):

MASARU KITAZAWA ◽

TAKASHI KATAGIRI ◽

HIROMI SUZUKI ◽

SATOSHI MATSUNAGA ◽

MAYUKO H. YAMADA ◽

...

Keyword(s):

Type 2 Diabetes ◽

Controlled Trial ◽

88-LB: Similar Efficacy and Safety of IGlarLixi When Initiated in Patients with Type 2 Diabetes (T2D) with or without Concomitant Sodium-Glucose Cotransporter-2 Inhibitor (SGLT2i) Use in a Randomized Controlled Trial (RCT) and Real-World Setting

Diabetes ◽

10.2337/db20-88-lb ◽

2020 ◽

Vol 69 (Supplement 1) ◽

pp. 88-LB

Author(s):

JULIO ROSENSTOCK ◽

AMAR ALI ◽

JURIS J. MEIER ◽

FRANCESCO GIORGINO ◽

CRISTIAN GUJA ◽

...

Keyword(s):

Type 2 Diabetes ◽

Real World ◽

Controlled Trial ◽

Similar Efficacy ◽

Efficacy And Safety ◽

Randomized Controlled ◽

Real World Setting ◽

Sodium Glucose Cotransporter